CLINICAL_TRIALS
trial_result
· 2020-11-02
Clinical Trial Update: DS-5565 Phase III Study for Post-herpetic Neuralgia [NA]
Summary
Phase III study for DS-5565 in post-herpetic neuralgia completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Post-Herpetic Neuralgia | NA | Status: COMPLETED | Results posted: 2020-11-02